Maxim Group Downgrades BioRestorative Therapies to Hold
Maxim Group analyst Michael Okunewitch downgrades BioRestorative Therapies (NASDAQ:BRTX) from Buy to Hold.
Stocks · News reference
8-K filing — BioRestorative Therapies, Inc. (BRTX)
Filed: 2026-10-09 AccNo: 0001213900-26-108467 Size: 198 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K/A filing — BioRestorative Therapies, Inc. (BRTX)
Filed: 2026-09-10 AccNo: 0001213900-26-098820 Size: 215 KB Item 4.01: Changes in Registrant's Certifying Accountant Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
BioRestorative Therapies shares are trading lower after the company announced a 1-for-20 reverse stock split.
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
Snowflake shares surged 24% after Q2 revenue and earnings beat estimates; other premarket gainers and losers made notable moves.
BioRestorative Therapies Announces 1-For-20 Reverse Stock Split
BioRestorative Therapies, Inc. (NASDAQ:BRTX) ("BioRestorative" or the "Company"), a late-stage clinical regenerative medicine company, today announced that the Company’s Board of Directors approved a
BioRestorative Therapies Announced Katharyn Field Stepped Aside As Interim CEO And CFO, Appointed Mika Grasso As Interim CEO Effective August 26, Steven Brown As Chairman Effective September 1, 2026